When Screening Goes Too Far: Rethinking Medical Testing in Older Adults
- Michelle Arnot
- 6 hours ago
- 2 min read
I've been resistant to standard medical tests all my life and Google has made it easier to become an educated consumer.
Sure, I understand that cancer screening is widely viewed as essential preventive care. Colonoscopies and mammograms are credited with saving lives through early detection. For many people in middle age, that is true. But in older adults, routine screening can become more complicated—and sometimes more harmful than helpful.
Statistics show a growing gap between guidelines and real-world practice:
About 30–40% of preventive screenings in U.S. adults over age 75 are considered low-value care, meaning they offer little expected benefit given life expectancy and health status.
Colonoscopy complications occur in roughly 2–6 per 1,000 procedures overall, with risks increasing significantly in older adults and those with chronic illness.
30–40% of adults over 70 report difficulty tolerating colonoscopy preparation, sometimes leading to dehydration or electrolyte imbalance.
For mammography, estimates suggest 10–30% of screen-detected breast cancers in older women may represent overdiagnosis—cancers that would never have caused symptoms.
20–50% of women screened annually over 10 years experience at least one false positive, often leading to additional imaging or biopsy.
About 1 in 10 abnormal mammograms leads to a biopsy, most of which are ultimately benign. Evidence for mammography benefits after age 75 is considered insufficient by the U.S. Preventive Services Task Force, meaning neither benefit nor harm can be clearly quantified.
These numbers point to a clear tension in American preventive care: screening remains widespread in older adults even when the expected benefit declines and the risks rise.
Colon cancer screening is generally recommended through age 75, with individualized decisions afterward, and often discontinued after 85 or in those with limited life expectancy. Mammography is typically recommended through age 74, with no clear evidence supporting routine use beyond that point.
Yet in practice, many older adults continue to receive routine colonoscopies and mammograms well past these thresholds. This happens because screening is deeply embedded in routine care, reinforced by patient expectations, fragmented medical systems, and clinician caution about missing a diagnosis.
The concern is not that screening is inherently harmful—it is that it is often applied without adjusting for age, frailty, and overall health. As a result, some older adults undergo procedures that carry real risk without a meaningful chance of extending life or improving its quality.
A more appropriate approach is individualized decision-making: not whether screening is “good” or “bad,” but whether it still aligns with a person’s health status and goals. For some older adults, continued screening is appropriate. For others, stepping back may represent better, more proportionate care.
The central question becomes simple: Does this test meaningfully improve this person’s life expectancy or quality of life?
In many cases, the answer is no.
Blog Editor's Note: The blog editor's grandpa had a screening in his early 70s that caught cancer. Because of the screening, his life was extended. Cases like his show the importance of not having a one-size-fits-all approach, because in his case, what the screening caught ended up extending his life significantly.
